AnaptysBio, Inc. (ANAB)
NASDAQ: ANAB · Real-Time Price · USD
53.36
-1.68 (-3.05%)
At close: Jul 31, 2026, 4:00 PM EDT
54.00
+0.64 (1.20%)
After-hours: Jul 31, 2026, 7:34 PM EDT

AnaptysBio Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
232.39234.691.2817.1610.2963.18
Revenue Growth
107.73%157.01%432.03%66.78%-83.72%-15.77%
Gross Profit
232.39234.691.2817.1610.2963.18
Operating Income
34.747.9-114.95-164.41-115.15-56.81
Net Income
-26.79-13.23-145.23-163.62-128.72-57.8
Earnings Per Share
-1.08-0.46-5.12-6.08-4.57-2.11
EPS Growth
------

Cash & Debt

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
286.46311.64385.37390.9441.24548.1
Total Debt
13.6114.1116.0417.8119.4520.96
Net Cash (Debt)
272.84297.53369.34373.09421.79527.14
Net Cash Growth
-15.88%-19.44%-1.01%-11.55%-19.98%34.03%
Net Cash Per Share
9.2610.3513.0113.8614.9819.22

Cash Flow & CapEx

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
4.4819.7-135.34-120.8-73.59-45.92
Capital Expenditures
-0.07-0.09-0.36-0.81-0.36-1.37
Free Cash Flow
4.4119.61-135.7-121.61-73.95-47.29
Free Cash Flow Growth
------

Margins

Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%100.00%100.00%100.00%
Operating Margin
14.93%20.42%-125.93%-958.27%-1119.41%-89.93%
Pretax Margin
-11.46%-5.57%-159.10%-953.68%-1251.09%-91.49%
Profit Margin
-11.53%-5.64%-159.11%-953.66%-1251.33%-91.49%
FCF Margin
1.90%8.36%-148.66%-708.79%-718.88%-74.85%

Valuation

Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Forward PE
29.9614.6814.6814.6814.6816.86
P/FCF Ratio
358.3469.27----
PS Ratio
6.805.794.4233.2185.9015.21